BUSINESSJun 18 · 00:39 UTCBLOOMBERGAvalon Pernell

Heart Health Biotech Kardigan Raises $400 Million in Upsized IPO

Kardigan, a heart health biotech company, raised $400 million in an upsized IPO. The company focuses on heart health innovations and has successfully secured significant funding through its initial public offering.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Kardiganorganizationheart healthtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSApr 30 · 22:54 UTC
Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO
HEALTHMay 8 · 15:58 UTC
Health Firms Odyssey, Mobia Slide After $454 Million IPO Haul
BUSINESSApr 27 · 11:25 UTC
Novo-Backed Biotech Hemab Seeks to Raise $212 Million in US IPO
BUSINESSMay 4 · 10:45 UTC
Immune System Biotech Odyssey Seeks $238.3 Million in US IPO
HEALTHMay 14 · 11:00 UTC
STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
BUSINESSApr 30 · 16:36 UTC
Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO